description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CGAAGAGATGGAGCAGCCTATGCAGAATGGAGAGGAAGACCGCCCTTTGGGAGGAGGTGAAGGCCACCAGCCTGCAGGAAATCGACGGGGACAGGCTCGCCGACTTGCCCCTAATTTTCGATGGGCCATACCCAATAGGCAGATCAATGATGGGATGGGTGGAGATGGAGATGATATGGAAATATTCATGGAGGAGATGAGAGAAATCAGAAGAAAACTTAGGGAGCTGCAGTTGAGGAATTGTCTGCGTATCCTTATGGGGGAGCTCTCTAATCACCATGACCATCATGATGAATTTTGCCTTATGCCTTGACTCCTGCCATTTATCATGAGATTAATACTGTGATTCCCGCTGTTTTCTTTTTCCTTGCATTTTCCTAATATGCCTTTACTGATCCGTTTGCTGTGAACCCTATGTTATTTCCATGTGTCAAGTGGGTCTTGTGTTGC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... BEX3(27018), NGFRAP1(27018)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Wei Gao et al.
Cancer medicine, 6(2), 439-451 (2017-01-14)
Nasopharyngeal carcinoma (NPC) can develop cisplatin-resistant phenotype. Research has revealed that enriched in cancer stem cell population is involved in developing cisplatin-resistant phenotype. CD271 is a candidate stem cell maker in head and neck cancers. The CD receptor does not
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持